Bayer Roundup Settlement of 7.25 Billion Approved by Judge
By Ganesh Karki
Key facts
- Section
- News
- Country
- USA
- Published
- 22 Nov 2026
A Missouri judge gave final approval on Friday 20 November to the Bayer Roundup settlement, a nationwide deal worth up to 7.25 billion dollars that could resolve thousands of lawsuits claiming the weedkiller Roundup caused cancer.
| Settlement | Up to 7.25 billion dollars, paid in annual instalments over up to 21 years |
| Court | St. Louis Circuit Court, Missouri; Judge Timothy Boyer |
| Claims covered | Current and future claims of non-Hodgkin lymphoma linked to Roundup exposure |
| Individual payouts | From 10,000 to 165,000 dollars, depending on exposure, age at diagnosis and severity |
| Attorneys fees | 600 million dollars included in the settlement |
What happened with the Bayer Roundup settlement
St. Louis Circuit Judge Timothy Boyer approved the nationwide class settlement, rejecting all objections. The deal covers two groups: people exposed to Roundup before 17 February 2026 who already have a diagnosis of non-Hodgkin lymphoma, and people who receive such a diagnosis before the end of a 16-year period after final approval. Bayer will make capped annual payments into a special fund over up to 21 years, totalling as much as 7.25 billion dollars, including payments already made. Judge Boyer said the average individual payouts are fair and adequate and the total is among the largest in the history of mass tort personal-injury class action settlements. Bayer chief executive Bill Anderson called the approval a decisive milestone in the company strategy to mitigate the risks of both pending and future Roundup litigation. Readers following USA business news can also read our report on Walmart third-quarter results, with revenue of 188 billion dollars.
What the Bayer Roundup settlement means
The settlement could finally resolve litigation that has weighed on Bayer for close to a decade, since it acquired Monsanto. It is unusual because it covers future claims as well as current ones, giving the company a capped, long-term route out of the Roundup cases rather than facing new lawsuits for years. The approval follows a June US Supreme Court ruling on whether plaintiffs could pursue state law claims over the absence of a cancer warning on the Roundup label, which Judge Boyer cited in finding the settlement met the test for adequacy. For farm workers and others who used the product, the deal opens a claims process with payouts based on how they used Roundup, how old they were when diagnosed and how severe their illness is.
What the sources do not say
The final approval order remains subject to appeal, and the sources do not say whether any objector will appeal or when the claims process will open. They do not state how many people are expected to claim, what the average payout will be in practice, or how the fund will be administered. The settlement does not establish that Roundup causes cancer: Bayer has consistently denied that the weedkiller causes cancer, and the sources do not say the company admitted liability.
Sources: WDRB, the AP report on the approval (7.25 billion dollars, payouts, judge comments, 21-year payments); Agri-Pulse, the settlement structure and the two claimant subclasses; NPR Illinois, the NPR report on the approval and the payout range.
Frequently asked questions
How much is the Bayer Roundup settlement worth?
Who can claim under the settlement?
How much will each person receive?
Sources and references
Information checked: 22 November 2026
Related stories
Las Vegas Grand Prix 2026: Verstappen Wins by 0.639 Seconds
Max Verstappen won the Las Vegas Grand Prix 2026 by 0.639 seconds from Lando Norris, his 75th career win, as late drama handed McLaren a double podium.
22 November 2026G20 Day Two: Leaders Face Decision on Joint Declaration
G20 day two brings a decision on Monday: a joint leaders declaration, a chair statement only, or no consensus outcome from Johannesburg.
22 November 2026HPE, Zoom and Agilent Report Earnings on Monday 23 November
Earnings Monday November 23 brings HPE, Zoom and Agilent results after the US close, plus November PMIs, after a brutal week for stocks.
22 November 2026Nvidia SEC Accounting Probe Deepens as Huang Agrees to Testify
The Nvidia SEC accounting probe deepened as Reuters reported accounting issues under review, while Jensen Huang agreed to testify before the US Senate.